| Patent | Date |
|---|
Blood plasma fractions for use in muscle regeneration
Grant 11,439,687 - Kheifets , et al. September 13, 2 | 2022-09-13 |
Treatment of aging-associated disease with modulators of leukotriene A4 hydrolase
Grant 11,426,399 - Campbell , et al. August 30, 2 | 2022-08-30 |
Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
Grant 11,413,308 - Braithwaite , et al. August 16, 2 | 2022-08-16 |
Treatment of Aging-Associated Disease with Modulators of Leukotriene A4 Hydrolase
App 20220226304 - Campbell; Meghan Kerrisk ; et al. | 2022-07-21 |
Methods and compositions for treating aging-associated impairments using CCR3-inhibitors
Grant 11,382,907 - Braithwaite , et al. July 12, 2 | 2022-07-12 |
Treatment of aging-associated disease with modulators of leukotriene A.sub.4 hydrolase
Grant 11,344,542 - Campbell , et al. May 31, 2 | 2022-05-31 |
Blood Plasma Fractions as a Treatment for Aging-Associated Cognitive Disorders
App 20220152161 - Bell; David ; et al. | 2022-05-19 |
Methods of improving wound healing
Grant 11,298,377 - Kheifets , et al. April 12, 2 | 2022-04-12 |
Dosing Regimen for Treatment of Cognitive and Motor Impairments with Blood Plasma and Blood Plasma Products
App 20210315932 - Braithwaite; Steven P. ; et al. | 2021-10-14 |
Methods and Compositions for Treating Aging-Associated Impairments with Trefoil Factor Family Member 2 Modulators
App 20210301013 - Czirr; Eva ; et al. | 2021-09-30 |
Blood Plasma Fractions for Use in Liver Regeneration
App 20210268021 - Kheifets; Viktoria ; et al. | 2021-09-02 |
Methods of improving or accelerating postoperative recovery
Grant 11,103,530 - Castro , et al. August 31, 2 | 2021-08-31 |
Methods For Screening Human Blood Products Comprising Plasma Using Immunocompromised Rodent Models
App 20210236656 - Braithwaite; Steven ; et al. | 2021-08-05 |
Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
Grant 11,040,068 - Braithwaite , et al. June 22, 2 | 2021-06-22 |
Methods and Compositions for Treating Aging-Associated Impairments with Trefoil Factor Family Member 2 Modulators
App 20210171626 - Czirr; Eva ; et al. | 2021-06-10 |
Blood Plasma Fractions for Use in Liver Regeneration
App 20210145875 - Kheifets; Viktoria ; et al. | 2021-05-20 |
Blood Plasma Fractions for Use in Muscle Regeneration
App 20210128693 - Kheifets; Viktoria ; et al. | 2021-05-06 |
Blood Plasma and Plasma Fractions as Therapy for Tumor Growth and Progression
App 20210113612 - Braithwaite; Steven P. ; et al. | 2021-04-22 |
Methods And Compositions For Treating Retina-associated Disease Using Ccr3-inhibitors
App 20210106577 - Coradini; Laura ; et al. | 2021-04-15 |
Use of Plasma and Plasma Fractions for Improvement of Pain, Wound Healing, and Postoperative Recovery
App 20210106616 - Castro; Marian ; et al. | 2021-04-15 |
Dosing Regimen for Treatment of Cognitive and Motor Impairments with Blood Plasma and Blood Plasma Products
App 20210060063 - Braithwaite; Steven P. ; et al. | 2021-03-04 |
Methods for screening human blood products comprising plasma using immunocompromised rodent models
Grant 10,905,779 - Braithwaite , et al. February 2, 2 | 2021-02-02 |
Blood plasma and plasma fractions as therapy for tumor growth and progression
Grant 10,905,717 - Braithwaite , et al. February 2, 2 | 2021-02-02 |
Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
Grant 10,874,692 - Braithwaite , et al. December 29, 2 | 2020-12-29 |
Use of CCR3-Inhibitors
App 20200375971 - Nivens; Michael Chadham ; et al. | 2020-12-03 |
Treatment of Aging-Associated Disease with Modulators of Leukotriene A4 Hydrolase
App 20200368220 - Campbell; Meghan Kerrisk ; et al. | 2020-11-26 |
Pharmaceutical Formulations Comprising CCR3 Antagonists
App 20200253950 - Kind Code | 2020-08-13 |
Use of Plasma and Plasma Fractions for Improvement of Pain, Wound Healing, and Postoperative Recovery
App 20200129549 - Castro; Marian ; et al. | 2020-04-30 |
Use of Plasma and Plasma Fractions for Improvement of Pain, Wound Healing, and Postoperative Recovery
App 20200129550 - Castro; Marian ; et al. | 2020-04-30 |
Methods and Compositions for Treating Aging-Associated Impairments Using CCR3-Inhibitors
App 20200054622 - Braithwaite; Steven P. ; et al. | 2020-02-20 |
Blood plasma fractions as a treatment for aging-associated cognitive disorders
Grant 10,525,107 - Bell , et al. J | 2020-01-07 |
Methods and compositions for treating aging-associated impairments
Grant 10,487,148 - Wyss-Coray , et al. Nov | 2019-11-26 |
Treatment of Aging-Associated Disease with Modulators of Leukotriene A4 Hydrolase
App 20190350917 - Campbell; Meghan Kerrisk ; et al. | 2019-11-21 |
Dosing Regimen for Treatment of Cognitive and Motor Impairments with Blood Plasma and Blood Plasma Products
App 20190328782 - Braithwaite; Steven P. ; et al. | 2019-10-31 |
Blood Plasma Fractions as a Treatment for Aging-Associated Cognitive Disorders
App 20190321449 - Bell; David ; et al. | 2019-10-24 |
Dosing Regimen for Treatment of Cognitive and Motor Impairments with Blood Plasma and Blood Plasma Products
App 20190282617 - Braithwaite; Steven P. ; et al. | 2019-09-19 |
Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
Grant 10,357,513 - Braithwaite , et al. July 23, 2 | 2019-07-23 |
Blood Plasma and Plasma Fractions as Therapy for Tumor Growth and Progression
App 20190167719 - Braithwaite; Steven P. ; et al. | 2019-06-06 |
Pharmaceutical Formulations Comprising CCR3 Antagonists
App 20190151300 - FETSCHER; Alfred ; et al. | 2019-05-23 |
Methods and Compositions for Treating Pruritus, Xerosis, and Associated Disease Using CCR-Inhibitors
App 20190111042 - Braithwaite; Steven P. ; et al. | 2019-04-18 |
Methods And Compositions For Treating Aging-associated Impairments
App 20190106495 - Wyss-Coray; Anton ; et al. | 2019-04-11 |
Methods and Compositions for Treating Aging-Associated Impairments Using CCR3-Inhibitors
App 20190105314 - Braithwaite; Steven P. ; et al. | 2019-04-11 |
Blood plasma and plasma fractions as therapy for tumor growth and progression
Grant 10,245,285 - Braithwaite , et al. | 2019-04-02 |
Pharmaceutical formulations comprising CCR3 antagonists
Grant 10,213,421 - Fetscher , et al. Feb | 2019-02-26 |
Dosing Regimen for Treatment of Cognitive and Motor Impairments with Blood Plasma and Blood Plasma Products
App 20180311280 - Braithwaite; Steven P. ; et al. | 2018-11-01 |
Methods And Compositions For Treating Aging-associated Impairments
App 20180298102 - Wyss-Coray; Anton ; et al. | 2018-10-18 |
Blood Plasma Fractions as a Treatment for Aging-Associated Cognitive Disorders
App 20180110839 - Bell; David ; et al. | 2018-04-26 |
Blood Plasma and Plasma Fractions as Therapy for Tumor Growth and Progression
App 20170340671 - Braithwaite; Steven P. ; et al. | 2017-11-30 |
Use of CCR3-Inhibitors
App 20170319567 - Nivens; Michael Chadham ; et al. | 2017-11-09 |
Methods For Screening Human Blood Products Comprising Plasma Using Immunocompromised Rodent Models
App 20170232118 - Braithwaite; Steven ; et al. | 2017-08-17 |
| 